SAM
Sectoral Asset Management’s Atea Pharmaceuticals AVIR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-600,461
| Closed | -$1.8M | – | 108 |
|
|
2023
Q3 | $1.8M | Buy |
600,461
+98,924
| +20% | +$297K | 0.35% | 87 |
|
|
2023
Q2 | $1.88M | Buy |
501,537
+120,687
| +32% | +$451K | 0.31% | 90 |
|
|
2023
Q1 | $1.28M | Buy |
380,850
+99,447
| +35% | +$333K | 0.25% | 90 |
|
|
2022
Q4 | $1.35M | Buy |
+281,403
| New | +$1.35M | 0.26% | 87 |
|
|
2021
Q3 | – | Sell |
-538,884
| Closed | -$11.6M | – | 128 |
|
|
2021
Q2 | $11.6M | Sell |
538,884
-800,000
| -60% | -$17.2M | 0.94% | 42 |
|
|
2021
Q1 | $82.7M | Sell |
1,338,884
-153,206
| -10% | -$9.46M | 6.27% | 1 |
|
|
2020
Q4 | $62.3M | Buy |
+1,492,090
| New | +$62.3M | 4.39% | 1 |
|